We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial: Anti-inflammatory drug development focusing on immune mediated diseases.
- Authors
Fernando Oliveira-Costa, José; Prasad, Amit
- Abstract
This editorial discusses the development of anti-inflammatory drugs for immune-mediated diseases, such as rheumatoid arthritis and multiple sclerosis. It highlights the challenges faced in developing countries like Brazil, where resources and specialized professionals are limited. The importance of ongoing research to identify new drugs with specific targets and fewer side effects is emphasized. The text mentions several studies exploring different approaches, including natural products, drug repurposing, and in silico modeling, to develop new immunomodulatory drugs for inflammatory diseases. It also discusses specific studies on potential treatments for psoriasis-like skin inflammation, dermatitis, skeletal muscle strength enhancement, stroke-associated pneumonia, and interstitial lung disease. The field of anti-inflammatory drug development is evolving, but researchers continue to face complexity and challenges in treating inflammatory diseases.
- Subjects
ANTI-inflammatory agents; DRUG development; SUGAMMADEX; THERAPEUTICS; PATHOLOGY
- Publication
Frontiers in Pharmacology, 2024, p1
- ISSN
1663-9812
- Publication type
Article
- DOI
10.3389/fphar.2024.1413141